logo

Pacira Pharmaceuticals, Inc. (PCRX)



Trade PCRX now with
  Date
  Headline
1/8/2018 7:40:34 AM WellStar Health System And Pacira Announce Joint Commitment To Address Opioid Use And Dependence Following Surgery
1/4/2018 7:39:00 AM Pacira Pharma Q4 Total Revenues Of $79.1 Mln Vs. $72.9 Mln Prior Year
12/7/2017 7:31:32 AM Pacira Promotes Scott Braunstein To COO And Richard Scranton To Chief Scientific Officer
11/22/2017 11:46:30 AM Wedbush Reiterates Pacira Pharmaceuticals, Inc. (PCRX) At Outperform With $80 Price Target
11/20/2017 7:08:50 AM Wedbush Reiterates Pacira Pharmaceuticals, Inc. (PCRX) At Outperform With $80 Down From $87 Price Target
11/20/2017 7:08:07 AM Wedbush Is Cutting Pacira Pharmaceuticals, Inc. (PCRX) 2018 Estimate To -1.62 From -0.67
11/20/2017 7:07:47 AM Wedbush Is Raising Pacira Pharmaceuticals, Inc. (PCRX) 2017 Estimate To -1.58 From -1.78
11/20/2017 7:06:57 AM Wedbush Is Lowering Pacira Pharmaceuticals, Inc. (PCRX) 2018 Rev. Estimate To 319.2 M From 370.2 M
11/20/2017 7:06:04 AM Wedbush Is Cutting Pacira Pharmaceuticals, Inc. (PCRX) 2017 Rev. Estimate To 285.6 M From 293.9 M
11/14/2017 7:35:11 AM Pacira Announces FDA Advisory Committee Meeting To Review SNDA For EXPAREL As Nerve Block For Regional Analgesia
11/8/2017 7:38:23 AM Pacira Pharma Q3 Total Revenues $67.3 Mln Vs $68.4 Mln Last Year
10/25/2017 9:57:50 AM Wedbush Is Lowering Pacira Pharmaceuticals, Inc. (PCRX) FY17 Rev. Estimate To 293.9 M From 302.7 M
10/25/2017 9:57:21 AM Wedbush Is Cutting Pacira Pharmaceuticals, Inc. (PCRX) FY17 Estimate To -1.78 From -1.65
10/25/2017 9:56:52 AM Wedbush Reiterates Pacira Pharmaceuticals, Inc. (PCRX) At Outperform With $87 Price Target
10/18/2017 7:33:02 AM Pacira : FDA Accepts SNDA For EXPAREL As Nerve Block To Produce Regional Analgesia
9/20/2017 10:15:59 AM Wedbush Reiterates Pacira Pharmaceuticals, Inc. (PCRX) At Ourperform With $87 Price Target
9/13/2017 7:34:07 AM Pacira , Aetna, And AAOMS Collabrate To Reduce Opioid Exposure For Patients Undergoing Wisdom Tooth Extraction
8/23/2017 9:40:59 AM Wedbush Reiterates Pacira Pharmaceuticals, Inc. (PCRX) At Outperform With $87 Price Target